LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.77 | 84.90 | 791 | 411 | 1.9235 | 1.6659 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 9.47 | 84.90 | 16 | 447 | 0.0358 | -0.5014 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 9.47 | 84.90 | 923 | 447 | 2.0629 | 1.7051 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 9.47 | 84.90 | 849 | 447 | 1.8975 | 1.6124 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 11.18 | 84.90 | 25 | 492 | 0.0508 | -0.3825 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 11.18 | 84.90 | 976 | 492 | 1.9823 | 1.6195 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 11.18 | 84.90 | 908 | 492 | 1.8442 | 1.5459 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.88 | 84.90 | 31 | 531 | 0.0584 | -0.3168 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.88 | 84.90 | 1016 | 531 | 1.9134 | 1.5561 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.88 | 84.90 | 14 | 531 | 0.0264 | -0.4941 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.88 | 84.90 | 949 | 531 | 1.7872 | 1.4910 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.58 | 84.90 | 33 | 663 | 0.0497 | -0.2728 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.58 | 84.90 | 1043 | 663 | 1.5722 | 1.3296 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.58 | 84.90 | 97 | 663 | 0.1462 | 0.0460 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.58 | 84.90 | 1013 | 663 | 1.5270 | 1.3068 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.29 | 84.90 | 34 | 766 | 0.0443 | -0.2504 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.29 | 84.90 | 1067 | 766 | 1.3914 | 1.2193 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.29 | 84.90 | 247 | 766 | 0.3221 | 0.3998 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.29 | 84.90 | 1076 | 766 | 1.4031 | 1.2251 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.99 | 84.90 | 45 | 898 | 0.0501 | -0.1701 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.99 | 84.90 | 1093 | 898 | 1.2158 | 1.1182 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.99 | 84.90 | 308 | 898 | 0.3426 | 0.4601 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 17.99 | 84.90 | 1094 | 898 | 1.2169 | 1.1187 | MN20160318_Q02 | F04 |